No headlines found.
ACCESSWIRE (Thu, 9-May 7:51 AM ET)
ACCESSWIRE (Tue, 9-Apr 7:32 AM ET)
ACCESSWIRE (Thu, 4-Apr 7:33 AM ET)
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
ACCESSWIRE (Thu, 28-Mar 4:03 PM ET)
ACCESSWIRE (Wed, 27-Mar 7:32 AM ET)
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.
Sonoma Pharmaceuticals trades on the NASDAQ stock market under the symbol SNOA.
As of May 17, 2024, SNOA stock price declined to $0.24 with 15,200,594 million shares trading.
SNOA has a beta of 4.33, meaning it tends to be more sensitive to market movements. SNOA has a correlation of 0.12 to the broad based SPY ETF.
SNOA has a market cap of $3.68 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, SNOA stock traded as high as $13.36 and as low as $.12.
The top ETF exchange traded funds that SNOA belongs to (by Net Assets): VXF.
SNOA stock has underperformed the market in the last year with a return of -76.9%, while SPY returned +29.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SNOA shares. However, SNOA has outperformed the market in the last 3 month and 2 week periods, returning +48.4% and +51.3%, while SPY returned +6.3% and +3.6%, respectively. This indicates SNOA has been having a stronger performance recently.
SNOA support price is $.23 and resistance is $.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNOA stock will trade within this expected range on the day.